Literature DB >> 27824592

Cell Signaling Pathways That Regulate Antigen Presentation.

Randy R Brutkiewicz1.   

Abstract

Cell signaling pathways regulate much in the life of a cell: from shuttling cargo through intracellular compartments and onto the cell surface, how it should respond to stress, protecting itself from harm (environmental insults or infections), to ultimately, death by apoptosis. These signaling pathways are important for various aspects of the immune response as well. However, not much is known in terms of the participation of cell signaling pathways in Ag presentation, a necessary first step in the activation of innate and adaptive T cells. In this brief review, I discuss the known signaling molecules (and pathways) that regulate how Ags are presented to T cells and the mechanism(s), if identified. Studies in this area have important implications in vaccine development and new treatment paradigms against infectious diseases, autoimmunity, and cancer.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27824592      PMCID: PMC5119928          DOI: 10.4049/jimmunol.1600460

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  129 in total

1.  Mobilization of MHC class I molecules from late endosomes to the cell surface following activation of CD34-derived human Langerhans cells.

Authors:  P A MacAry; M Lindsay; M A Scott; J I Craig; J P Luzio; P J Lehner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Molecular mechanisms of TLR2-mediated antigen cross-presentation in dendritic cells.

Authors:  Kuan-Yin Shen; Ying-Chyi Song; I-Hua Chen; Chih-Hsiang Leng; Hsin-Wei Chen; Hui-Ju Li; Pele Chong; Shih-Jen Liu
Journal:  J Immunol       Date:  2014-03-28       Impact factor: 5.422

Review 3.  Modulation of antigen presentation by intracellular trafficking.

Authors:  Justine D Mintern; Christophe Macri; Jose A Villadangos
Journal:  Curr Opin Immunol       Date:  2015-01-09       Impact factor: 7.486

4.  Interferon-gamma-induced MHC class I expression and defects in Jak/Stat signalling in methylcholanthrene-induced sarcomas.

Authors:  I M Svane; A M Engel; M Nielsen; O Werdelin
Journal:  Scand J Immunol       Date:  1997-10       Impact factor: 3.487

5.  TLR signals induce phagosomal MHC-I delivery from the endosomal recycling compartment to allow cross-presentation.

Authors:  Priyanka Nair-Gupta; Alessia Baccarini; Navpreet Tung; Fabian Seyffer; Oliver Florey; Yunjie Huang; Meenakshi Banerjee; Michael Overholtzer; Paul A Roche; Robert Tampé; Brian D Brown; Derk Amsen; Sidney W Whiteheart; J Magarian Blander
Journal:  Cell       Date:  2014-07-31       Impact factor: 41.582

6.  The role of the p38 mitogen-activated protein kinase, extracellular signal-regulated kinase, and phosphoinositide-3-OH kinase signal transduction pathways in CD40 ligand-induced dendritic cell activation and expansion of virus-specific CD8+ T cell memory responses.

Authors:  Qigui Yu; Colin Kovacs; Feng Yun Yue; Mario A Ostrowski
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

7.  c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 signaling pathways have divergent roles in CD8(+) T cell-mediated antiviral immunity.

Authors:  Nathalie Arbour; Denise Naniche; Dirk Homann; Roger J Davis; Richard A Flavell; Michael B A Oldstone
Journal:  J Exp Med       Date:  2002-04-01       Impact factor: 14.307

Review 8.  Phagosomal TLR signaling upon Borrelia burgdorferi infection.

Authors:  Jorge L Cervantes; Kelly L Hawley; Sarah J Benjamin; Bennett Weinerman; Stephanie M Luu; Juan C Salazar
Journal:  Front Cell Infect Microbiol       Date:  2014-05-20       Impact factor: 5.293

Review 9.  Subverting Toll-Like Receptor Signaling by Bacterial Pathogens.

Authors:  Victoria A McGuire; J Simon C Arthur
Journal:  Front Immunol       Date:  2015-12-01       Impact factor: 7.561

Review 10.  Targeting toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases.

Authors:  Athina Savva; Thierry Roger
Journal:  Front Immunol       Date:  2013-11-18       Impact factor: 7.561

View more
  16 in total

1.  Enriched Cd141+ DCs in the joint are transcriptionally distinct, activated, and contribute to joint pathogenesis.

Authors:  Mary Canavan; Alice M Walsh; Vipul Bhargava; Sarah M Wade; Trudy McGarry; Viviana Marzaioli; Barry Moran; Monika Biniecka; Hannah Convery; Siobhan Wade; Carl Orr; Ronan Mullan; Jean M Fletcher; Sunil Nagpal; Douglas J Veale; Ursula Fearon
Journal:  JCI Insight       Date:  2018-12-06

Review 2.  Immune evasion of the CD1d/NKT cell axis.

Authors:  Randy R Brutkiewicz; Laura Yunes-Medina; Jianyun Liu
Journal:  Curr Opin Immunol       Date:  2018-05-04       Impact factor: 7.486

Review 3.  Innate Control of Adaptive Immunity: Beyond the Three-Signal Paradigm.

Authors:  Aakanksha Jain; Chandrashekhar Pasare
Journal:  J Immunol       Date:  2017-05-15       Impact factor: 5.422

4.  JNK2 modulates the CD1d-dependent and -independent activation of iNKT cells.

Authors:  Jianyun Liu; Richard M Gallo; Masood A Khan; Abhirami K Iyer; Ian M Kratzke; Randy R Brutkiewicz
Journal:  Eur J Immunol       Date:  2018-12-03       Impact factor: 5.532

5.  IL-27 and TCR Stimulation Promote T Cell Expression of Multiple Inhibitory Receptors.

Authors:  Jonathan H DeLong; Aisling O'Hara Hall; Matt Rausch; Devapregasan Moodley; Joseph Perry; Jeongho Park; Anthony T Phan; Daniel P Beiting; Ross M Kedl; Jonathan A Hill; Christopher A Hunter
Journal:  Immunohorizons       Date:  2019-01-15

6.  Linking species habitat and past palaeoclimatic events to evolution of the teleost innate immune system.

Authors:  Monica Hongrø Solbakken; Kjetil Lysne Voje; Kjetill Sigurd Jakobsen; Sissel Jentoft
Journal:  Proc Biol Sci       Date:  2017-04-26       Impact factor: 5.349

Review 7.  Interleukin-1 as Innate Mediator of T Cell Immunity.

Authors:  Bram Van Den Eeckhout; Jan Tavernier; Sarah Gerlo
Journal:  Front Immunol       Date:  2021-01-27       Impact factor: 7.561

8.  Delivery of toll-like receptor agonists by complement C3-targeted liposomes activates immune cells and reduces tumour growth.

Authors:  Alexandra Francian; Ashley Widmer; Troy Olsson; Marisabel Ramirez; Darion Heald; Keaton Rasic; Luke Adams; Holly Martinson; Max Kullberg
Journal:  J Drug Target       Date:  2021-02-01       Impact factor: 5.016

9.  Airway epithelial TSLP production of TLR2 drives type 2 immunity in allergic airway inflammation.

Authors:  Jiajia Lv; Qianying Yu; Jie Lv; Caixia Di; Xiaoliang Lin; Wen Su; Min Wu; Zhenwei Xia
Journal:  Eur J Immunol       Date:  2018-10-12       Impact factor: 5.532

10.  Platelet P-selectin initiates cross-presentation and dendritic cell differentiation in blood monocytes.

Authors:  Patrick Han; Douglas Hanlon; Najla Arshad; Jung Seok Lee; Kazuki Tatsuno; Eve Robinson; Renata Filler; Olga Sobolev; Christine Cote; Felix Rivera-Molina; Derek Toomre; Tarek Fahmy; Richard Edelson
Journal:  Sci Adv       Date:  2020-03-11       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.